WHO WHO Updates Recommendations to Improve Access to Rapid MDx Tests for TB, Drug-Resistant TB The WHO recommended moderate-complexity, automated nucleic acid amplification test for the initial detection of TB and resistance to rifampicin and isoniazid. Rockefeller Foundation Funds Global Pathogen Sequencing With $20M, Forms Collaborations The funding and alliances mark the first step in the foundation's establishment of a pandemic prevention institute, which will collaborate with similar efforts elsewhere. Roche Cobas HIV, Hepatitis C Tests Nab WHO Prequalification Prequalification from the World Health Organization indicates that products meet high quality standards and are safe for their intended use. WHO Finds High Diagnostic Accuracy in Three Classes of MDx Technologies for TB Testing, Resistance The findings stem from a recent meeting of a WHO Guideline Development Group convened to address challenges with TB diagnosis and related drug-resistance. FNIH Panel on Gene Drive Regulation Emphasizes Need for Local Community Engagement Premium Researchers are hoping to make the technology a success for the environment and human health while avoiding the biases that resulted from the debate over GMOs. Sep 8, 2020 As Flu Season Nears, Dx Companies Shift Attention to Multiplex Tests for SARS-CoV-2, Influenza Premium Sep 8, 2020 Roche BK Virus Test Garners FDA Clearance Sep 3, 2020 International Commission Deems Germline Genome Editing Not Yet Safe in Human Embryos Premium Jul 17, 2020 Cepheid Debuts 10-Color Molecular Detection Technology With New Tuberculosis Test Premium May 5, 2020 Genedrive Hepatitis C Test Garners WHO Prequalification, Firm Plans £8M Raise Apr 8, 2020 Novacyt, AstraZeneca, GSK, University of Cambridge Partner to Increase SARS-CoV-2 Testing in UK Feb 20, 2020 FIND, WHO Collaborate on Novel Coronavirus MDx Evaluation Jan 23, 2020 Diagnostics Developers Leap Into Action on Novel Coronavirus Tests Premium Aug 15, 2019 Germline Genome Editing Governance Weighed by International Commission Premium May 22, 2019 International Scientific Societies Launch Commission on Clinical Use of Human Genome Editing Mar 7, 2019 CRISPR License Agreements Prohibit Misuse, but Enforcement is Challenging Premium Jan 16, 2018 Hologic Receives WHO Prequalification for HIV Assay, Initiates $1B Senior Notes Offering Aug 30, 2017 Study Highlights Cepheid's Next-Generation TB, Rifampicin Resistance Assay Premium Jul 7, 2017 Dartmouth-Led Team Wins $12.1M NIH Grant for Lung Cancer Research Jun 12, 2017 New Lung Cancer Susceptibility Loci Discovered in GWAS Nov 3, 2016 Bioneer Zika Detection Kit Eligible for WHO Procurement Sep 1, 2016 Zika Genome Sequence of World Health Organization Reference Strain Will Aid Diagnostic Assays Aug 19, 2016 Altona Diagnostics Zika Test Gains WHO Prequalification Status Jul 5, 2016 Exact Sciences, GenMark Diagnostics Stand Out in June GWDN Index as Brexit Fears Push Stocks Down Jun 16, 2016 HIV Tests From Alere, Cepheid Get WHO Prequalification, Unlocking New Markets Premium Load More Breaking News People in the News at Pacific Biosciences, Metabolon, NeoGenomics, More New Products Posted to GenomeWeb: Tethis, Invitae, PerkinElmer, More In Brief This Week: Thermo Fisher Scientific, Bruker, Quantum-Si, BioMérieux, More Luminex Obtains CE Marking for MDx Panel to Detect Flu A/B, RSV, COVID-19 Palmetto Finalizes Positive LCD for Prostate Cancer Risk Tests Gene Expression, Histology Reveal Clues for Targeted Rheumatoid Arthritis Treatment The Scan Call for a Different Tack Experts weigh the value of recent experiments testing genetically modified pig kidneys using brain-dead individuals, according to Nature News. Wastewater Warning The New York Times reports that wastewater surveillance in some parts of the US point to a possible surge. Can't Get in the Program Due to the Northern Ireland protocol dispute, the European Union is preventing UK researchers from joining the Horizon Europe research program, the Times of London reports. Science Paper on Spatial-Controlled Genome Editing In Science this week: approach to enable a CRISPR-Cas13a-based system to be used as a cancer therapy.